| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1721 | 2020 |
| Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy H Jiang, S Hegde, BL Knolhoff, Y Zhu, JM Herndon, MA Meyer, ... Nature medicine 22 (8), 851-860, 2016 | 895 | 2016 |
| MDSC: Markers, development, states, and unaddressed complexity S Hegde, AM Leader, M Merad Immunity 54 (5), 875-884, 2021 | 355 | 2021 |
| Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer S Hegde, VE Krisnawan, BH Herzog, C Zuo, MA Breden, BL Knolhoff, ... Cancer cell 37 (3), 289-307. e9, 2020 | 316 | 2020 |
| Sinai Immunology Review Project. Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 271 | 2020 |
| Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy H Jiang, S Hegde, DG DeNardo Cancer Immunology, Immunotherapy 66 (8), 1037-1048, 2017 | 198 | 2017 |
| Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies RZ Panni, JM Herndon, C Zuo, S Hegde, GD Hogg, BL Knolhoff, ... Science translational medicine 11 (499), eaau9240, 2019 | 167 | 2019 |
| Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion H Jiang, X Liu, BL Knolhoff, S Hegde, KB Lee, H Jiang, RC Fields, ... Gut 69 (1), 122-132, 2020 | 104 | 2020 |
| Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma A Magen, P Hamon, N Fiaschi, BY Soong, MD Park, R Mattiuz, E Humblin, ... Nature medicine 29 (6), 1389-1399, 2023 | 76 | 2023 |
| A skin-depth analysis of integrins: role of the integrin network in health and disease S Hegde, S Raghavan Cell communication & adhesion 20 (6), 155-169, 2013 | 56 | 2013 |
| TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer MD Park, I Reyes-Torres, J LeBerichel, P Hamon, NM LaMarche, ... Nature immunology 24 (5), 792-801, 2023 | 43 | 2023 |
| Low-barrier hydrogen bonds in proteins MV Hosur, R Chitra, S Hegde, RR Choudhury, A Das, RV Hosur Crystallography reviews 19 (1), 3-50, 2013 | 31 | 2013 |
| Sterile inflammation enhances ECM degradation in integrin β1 KO embryonic skin AS Kurbet, S Hegde, O Bhattacharjee, S Marepally, PK Vemula, ... Cell reports 16 (12), 3334-3347, 2016 | 26 | 2016 |
| Does asthma make COVID-19 worse? S Hegde Nature Reviews Immunology 20 (6), 352-352, 2020 | 22 | 2020 |
| An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis NM LaMarche, S Hegde, MD Park, BB Maier, L Troncoso, J Le Berichel, ... Nature 625 (7993), 166-174, 2024 | 13 | 2024 |
| Intratumoral mregDC and CXCL13 T helper niches enable local differentiation of CD8 T cells following PD-1 blockade A Magen, P Hamon, N Fiaschi, L Troncoso, E Humblin, D D’souza, ... BioRxiv, 2022.06. 22.497216, 2022 | 9 | 2022 |
| On the biology and therapeutic modulation of macrophages and dendritic cells in cancer MD Park, M Belabed, ST Chen, P Hamon, S Hegde, R Mattiuz, TU Marron, ... Annual Review of Cancer Biology 7, 291-311, 2023 | 6 | 2023 |
| A phase 1b/2 trial of dupilumab given in conjunction with PD-(L) 1 blockade in the treatment of relapsed/refractory metastatic NSCLC. BG Fitzgerald, TU Marron, N Hall, D O'Grady, N LaMarche, C Hennequin, ... Journal of Clinical Oncology 40 (16_suppl), TPS9139-TPS9139, 2022 | 2 | 2022 |
| TREM2 sensing of tumor cell efferocytosis promotes a macrophage molecular state that limits NK cell antitumor immunity I Reyes-Torres, M Park, A Magen, P Hamon, ... | 2 | 2021 |
| Immunology of COVID-19: current state of the science M Agrawal, M Aleynick, M Belabed, G Britton, M Brown, ... | 2 | 2020 |
David DeNardoWashington University, St. Louis, School of Medicine在 wustl.edu 的电子邮件经过验证
